Fortis Advisors, LLC Gilead Sciences, Inc. Transaction History

Fortis Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $245,384 - $314,301	-3,918 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $244,914 - $270,342	3,918 New	3,918 $248,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $174,333 - $195,299	-2,788 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $150,744 - $196,710	2,490 Added 835.57%	2,788 $174,000
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $21,706 - $26,462	298 New	298 $22,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.